Inactive Instrument

Highlights Good Works II Acquisition Corp. Nasdaq

Equities

Direct Biologics LLC cancelled the acquisition of Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others in a reverse merger transaction.	23-02-14	CI
Good Works II Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-25	CI
Good Works II Acquisition, Direct Biologics Enter SPAC Merger Deal	22-10-13	MT
Direct Biologics to list in U.S. via $1 billion SPAC	22-10-13	RE
Good Works II Acquisition Signs Letter of Intent for Business Combination With Direct Biologics	22-09-27	MT
Direct Biologics LLC announced that it expects to receive $100 million in funding from IB Investments 1 LLC, and other investors	22-09-26	CI
Direct Biologics LLC entered into a non-binding letter of intent to acquire Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others for approximately $630 million in a reverse merger transaction.	22-09-26	CI
Good Works II Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-27	CI
Good Works II Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-03	CI
Good Works II Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-17	CI
Good Works II Acquisition Corp. has completed an IPO in the amount of $200 million.	21-07-09	CI
Good Works II Acquisition Corp. has filed an IPO in the amount of $200 million.	21-03-18	CI

No results for this search